Biotech Catches Major Premarket Bid Following FDA Approval
03 Avril 2024 - 4:25PM
AllPennyStocks.com
A Washington D.C.-based biotech is causing
quite the stir so far during Wednesday’s premarket after the
company’s Fanapt received FDA approval for the acute
treatment...
To read the full story on AllPennyStocks.com, click
here.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024